Stat3 as an oncogene

Cell

Volumn 98, Issue 3, 1999, Pages 295-303

  Bromberg, Jacqueline F ^a   Wrzeszczynska, Melissa H ^a   Devgan, Geeta ^a   Zhao, Yanxiang ^a   Pestell, Richard G ^b   Albanese, Chris ^b   Darnell Jr , James E ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAT3 PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL TRANSFORMATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR GROWTH;

ANIMALIA; MUS MUSCULUS;

EID: 0033529704     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81959-5     Document Type: Article

References (49)

1. Adams, J.M., and Cory, S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science 287, 1322-1326.
2. Alexander, W.S., Metcalf, D., and Dunn, A.R. (1995). Point mutations within a dimer interface homology domain of c-M pi induce constitutive receptor activity and tumorigenicity. EMBO J. 14, 5569-5578.
3. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. (1994). Current Protocols in Molecular Biology (New York: John Wiley & Sons, Inc.).
4. Benitah, J.-P., Ranjan, R., Yamagishi, T., Janecki, M., Tomaselli, G.F., and Marban, E. (1997). Molecular motions within the pore of voltage-dependent sodium channels. Biophys. J. 73, 603-613.
5. Besser, D., Bromberg, J.F., Darnell, J.E., Jr., and Hanafusa, H. (1999). A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol. Cell. Biol. 19, 1401-1409.
6. Boulton, T.G., Zhong, Z., Wen, Z., Darnell, J.E., Jr., and Yancopoulos, G.D. (1995). Stat3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA 92, 6915-6919.
7. Bromberg, J.F., Horvath, C.M., Wen, Z., Schreiber, R.D., and Darnell, J.E., Jr. (1996). Transcriptionally active Stat1 is required for the antiproliferative effects of both IFN-α and IFN-γ. Proc. Natl. Acad. Sci. USA 93, 7673-7678.
8. Bromberg, J.F., Horvath, C.M., Besser, D., Lathem, W.W., and Darnell, J.E., Jr. (1998). Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18, 2553-2558.
9. Catlett-Falcone, R., Landowski, T.H., Oshiro, M.M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L, Fernandez-Luna, J.L., Nunez, G., Dalton, W.S., and Jove, R. (1999). Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105-115.
10. Chen, X., Vinkemeier, U., Zhao, Y., Jeruzalmi, D., Darnell, J.E., Jr., and Kuriyan, J. (1998). Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93, 827-839.
11. Gory, S., Vaux, D.L., Strasser, A., Harris, A.W., and Adams, J.M. (1999). Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res. 59, 1685S-1692S.
12. Darnell, J.E., Jr. (1997). STATs and gene regulation. Science 277, 1630-1635.
13. Garcia, R., and Jove, R. (1998). Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J. Biomed. Sci. 5, 79-85.
14. Grandis, J.R., Drenning, S.D., Chakraborty, A., Zhou, M.Y., Zeng, Q., Pitt, A.S., and Tweardy, D.J. (1998). Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J. Clin. Invest. 102, 1385-1392.
15. Haspel, R.L., Salditt-Georgieff, M., and Darnell, J.E., Jr. (1996). The rapid inactivation of nuclear tyiosine phosphorylated Stat1 depends on a protein tyiosine phosphatase. EMBO J. 15, 6262-6268.
16. Hattori, M., Abraham, L.J., Northemann, W., and Fey, G.H. (1990). Acute-phase reaction induces a specific complex between hepatic nuclear proteins and the interleukin 6 response element of the rat α2-macioglobulin gene. Proc. Natl. Acad. Sci. USA 87, 2364-2368.
17. Heinrich, P.C., Horn, F., Graeve, L., Dittrich, E., Kerr, I., Grotzinger, J., and Wollmer, A. (1998). lnterleukin-6 and related cytokines: effect on the acute phase reaction. Z. Ernahrungswiss 37, 43-49.
18. Horvath, C.M., and Darnell, J.E., Jr. (1996). The antiviral state induced by alpha Interferon and gamma Interferon requires transcriptionally active Stal1 protein. J. Virol. 70, 647-650.
19. Kaplan, M.H., Schindler, U., Smiley, S.T., and Grusby, M.J. (1996). Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4, 313-319.
20. Kaplan, D.H., Shankaran, V., Dighe, A.S., Stocken, E., Aguet, M., Old, L.J., and Schreiber, R.D. (1998). Demonstration of an Interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95, 7556-7561.
21. Kimura, G., Itagaki, A., and Summers, J. (1975). Rat cell line 3y1 and its virogenic polyoma- and sv40-transformed derivatives. Int. J. Cancer 15, 694-706.
22. Lee, R.J., Albanese, C., Stenger, R.J., Watanabe, G., Inghirami, G., Haines, G.K., 3rd, Webster, M., Muller, W.J., Brugge, J.S., Davis, R.J., and Pestell, R.G. (1999). pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signalregulated kinase, p38, and Jun kinase pathways. A role for c-AMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. J. Biol. Chem. 274, 7341-7350.
23. Liu, X., Robinson, G.W., Wagner, K.-U., Garrett, L., Wynshaw-Boris, A., and Hennighausen, L. (1997). StatSa is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11, 179-186.
24. Lodish, H., Baltimore, D., Berk, A., Zipursky, S.L., Matsudaira, P., and Darnell, J. (1995). Molecular Cell Biology, 3rd Ed. (New York: Sci. Amer. Books), p. 1247-1294,
25. Matsumura, I., Kitamura, T., Wakao, H., Tanaka, H., Hashimoto, K., Albanese, C., Downward, J., Pestell, R.G., and Kanakura, Y. (1999). Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18, 1367-1377.
26. Novak, U., Ji, H., Kanagasundaram, V., Simpson, R., and Paradiso, L. (1998). STAT3 forms stable homodimers in the presence of divalent cations prior to activation. Biochem. Biophys. Res. Commun. 247, 558-563.
27. Onishi, M., Nosaka, T., Misawa, K., Mui, A.L., Gorman, D., McMahon, M., Miyajima, A., and Kitamura, T. (1998). Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol. 18, 3871-3879.
28. Schaefer, T.S., Sanders, L.K., and Nathans, D. (1995). Cooperative transcriptional activity of Jun and Stat3β, a short form of Stat3. Proc. Natl. Acad. Sci. USA 92, 9097-9101.
29. + channels. Biochemistry 35, 12133-12140.
30. Shuai, K., Schindler, C., Prezioso, V.R., and Darnell, J.E., Jr. (1992). Activation of transcription by IFN-γ: tyiosine phosphorylation of a 91 kDa DNA binding protein. Science 259, 1808-1812.
31. Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H., and Schreiber, R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
32. Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S., Nakanishi, K., Yoshida, N., Kishimoto, T., and Akira, S. (1996). Essential role of Stat6 in IL-4 signaling. Nature 380, 627-630.
33. Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., and Akira, S. (1998). Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161, 4652-4660.
34. Takeda, K., Clausen, B.E., Kaisho, T., Tsujimura, T., Terada, N., Forster, I., and Akira, S. (1999). Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10, 39-49.
35. Teglund, S., McKay, C., Schuetz, E., van Deursen, J.M., Stravopodis, D., Wang, D., Brown, M., Bodner, S., Grosveld, G., and Ihle, J.N. (1998). Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93, 841-850.
36. Tell, G., Scaloni, A., Pellizzari, L., Formisano, S., Pucillo, C., and Damante, G. (1998). Redox potential controls the structure and DNA binding activity of the paired domain. J. Biol. Chem. 273, 25062-25072.
37. Thierfelder, W.E., van Deursen, J.M., Yamamoto, K., Tripp, R.A., Sarawar, S.R., Carson, R.T., Sangster, M.Y., Vignali, D.A., Doherty, P.C., Grosveld, G.C., and Ihle, J.N. (1996). Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174.
38. Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R.P., and Jove, R. (1998). Stat3 activation by src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18, 2545-2552.
39. Udy, G.B., Towers, R.P., Snell, R.G., Wilkins, R.J., Park, S.-H., Ram, P.A., Waxman, D.J., and Davey, H.W. (1997). Requirement of Stat5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94, 7239-7244.
40. Vinkemeier, U., Cohen, S.L., Moarefi, I., Chait, B.T., Kuriyan, J., and Darnell, J.E., Jr. (1996). DNA binding of in vitro activated Stat1α, Stat1β, and truncaled Stat1: interaction between NH2 terminal domains stabilizes binding of two dimers lo tandem DNA sites. EMBO J. 15, 5616-5626.
41. Wagner, B.J., Hayes, T.E., Hoban, C.J., and Cochran, B.H. (1990). The SIF binding element confers sis/PDGF inducibilily onto Ihe c-fos promoler. EMBO J. 9, 4477-4484.
42. Watowich, S.S., Hilton, D.J., and Lodish, H.F. (1994). Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol. Cell. Biol. 14, 3535-3549.
43. Weber-Nordt, R.M., Mertelsmann, R., and Finke, J. (1998). The JAK-STAT pathway: signal transduction involved in proliferafion, differentiation and transformation. Leuk. Lymphoma 28, 459-467.
44. Wen, Z., Zhong, Z., and Darnell, J.E., Jr. (1995). Maximal activation of transcription of Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
45. Yu, C.L., Meyer, D., Campbell, G.S., Lamer, A.C., Carter-Su, C., Schwartz, J., and Jove, R. (1995). Enhanced DNA-binding of a Stat3-related protein in cells transformed by the src oncoprotein. Science 269, 81-83.
46. Zhong, Z., Wen, Z., and Darnell, J.E., Jr. (1994a). Stat3 and Stat4: members of fhe family of signal transducers and activators of transcription. Proc. Natl. Acad. Sci. USA 91, 4806-4810.
47. Zhong, Z., Wen, Z., and Darnell, J.E., Jr. (1994b). Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95-98.
48. Zhu, X., Wen, Z., Xu, L.Z., and Darnell, J.E., Jr. (1997). Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol. Cell. Biol. 17, 6618-6623.
49. Zong, C., Yan, R., August, A., Darnell, J.E., Jr., and Hanafusa, H. (1996). Unique signal fransduction of Eyk: constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J. 15, 4515-4525.